Revival Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the safety and efficacy topline analysis includes sequential organ failure assessment (SOFA) scores and mortality for the 28-day period post treatment.Efficacy: Stand-alone analysis of the Allocetra™-treated patients, of which 78% had septic shock and 65% had invasive ventilation at screening, demonstrated substantial reductions in SOFA scores and 65% reduction in overall morta ....

United States , Shachar Shlosberger , Oren Hershkovitz , Bruno Fran , Limoges Clinical Investigation Center , Enlivex Therapeutics Ltd , Exchange Commission , Adjudication Committee , High Risk , Harbor Statement , Private Securities Litigation Reform Act , Annual Report , Revival Phase , Astonish Phase , European Urology Focus Volume , Urinary Tract Infections , Invasive Ventilation , Septic Shock , Mortality Rate , Urinary Tract , Sofa Score , Relative Effect , Placebo Group ,